Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

John Fleming Biography and Net Worth

Director of USANA Health Sciences

Mr. Fleming is a student, researcher and advocate of the direct selling channel of distribution. His many years of involvement with the direct selling business model has been through actual involvement as an independent contractor, owner of a direct selling company, officer of one of the world’s largest direct selling companies, and Publisher/Editor-in-Chief of the most notable trade publication concerning direct sales. Since 2006, he has served as founder and CEO of Ideas and Design Group, a consulting firm that services business models that utilize independent contractors to market products and services. From 2006-2015, Mr. Fleming served as Publisher and Editor-in-Chief of Direct Selling News, the most notable trade publication for executives and companies that utilize the direct selling channel of distribution. Prior to that, Mr. Fleming held a variety of executive positions with Avon, one of the largest direct selling companies in the world.

What is John Turman Fleming's net worth?: The estimated net worth of John Turman Fleming is at least $84,951.82 as of July 31st, 2024. Mr. Fleming owns 2,503 shares of USANA Health Sciences stock worth more than $84,952 as of December 23rd. This net worth estimate does not reflect any other investments that Mr. Fleming may own. Learn More about John Turman Fleming's net worth.
How do I contact John Turman Fleming?: The corporate mailing address for Mr. Fleming and other USANA Health Sciences executives is 3838 West Parkway Blvd, Salt Lake City UT, 84120. USANA Health Sciences can also be reached via phone at (801) 954-7100 and via email at [email protected]. Learn More on John Turman Fleming's contact information.
Has John Turman Fleming been buying or selling shares of USANA Health Sciences?: John Turman Fleming has not been actively trading shares of USANA Health Sciences within the last three months. Most recently, John Turman Fleming sold 1,000 shares of the business's stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $44.43, for a transaction totalling $44,430.00. Following the completion of the sale, the director now directly owns 2,503 shares of the company's stock, valued at $111,208.29. Learn More on John Turman Fleming's trading history.
Who are USANA Health Sciences' active insiders?: USANA Health Sciences' insider roster includes Robert Auciaux (Director), Jim Brown (President), John Fleming (Director), Joshua Foukas (Insider), Gilbert Fuller (Director), G. Iiekking (CFO), Daniel Macuga (Insider), David Mulham (Insider), Brent Neidig (Insider), Walter Noot (COO), Feng Peng (Director), Robert Sinnott (Insider), Myron Wentz (Major Shareholder), and Frederic Winssinger (Director). Learn More on USANA Health Sciences' active insiders.
Are insiders buying or selling shares of USANA Health Sciences?: In the last twelve months, insiders at the sold shares 16 times. They sold a total of 65,013 shares worth more than $2,996,013.52. The most recent insider tranaction occured on November, 4th when Director Gilbert A. Fuller sold 675 shares worth more than $25,454.25. Insiders at USANA Health Sciences own 0.3% of the company. Learn More about insider trades at USANA Health Sciences.
Information on this page was last updated on 11/4/2024.

John Turman Fleming Insider Trading History at USANA Health Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/31/2024	Sell	1,000	$44.43	$44,430.00	2,503
3/4/2024	Sell	300	$48.99	$14,697.00	3,013
12/12/2023	Sell	312	$49.73	$15,515.76	2,822
5/5/2023	Sell	1,250	$67.04	$83,800.00	2,153
8/30/2021	Sell	300	$97.26	$29,178.00	851

John Turman Fleming Buying and Selling Activity at USANA Health Sciences

USANA Health Sciences Company Overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $33.94

$31.44

$34.50

50 Day Range

MA: $37.88

$33.38

$41.29

2 Week Range

Now: $33.94

$31.44

$54.81

Volume

171,427 shs

Average Volume

84,401 shs

Market Capitalization

$646.90 million

P/E Ratio

11.99

Dividend Yield

N/A

Beta

0.89

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.